RYBELSUS Trademark

Trademark Overview


On Wednesday, August 28, 2024, a trademark application was filed for RYBELSUS with the United States Patent and Trademark Office. The USPTO has given the RYBELSUS trademark a serial number of 79413748. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 2, 2025. This trademark is owned by Novo Nordisk A/S. The RYBELSUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes.
rybelsus

General Information


Serial Number79413748
Word MarkRYBELSUS
Filing DateWednesday, August 28, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, January 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diabetes.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 2, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Thursday, January 2, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB